|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:awards
|
Best Biotech Company 2022
|
|
gptkbp:ceo
|
gptkb:John_Doe
|
|
gptkbp:certification
|
gptkb:ISO_9001
|
|
gptkbp:clinical_trial
|
ongoing
|
|
gptkbp:collaborations
|
pharmaceutical companies
|
|
gptkbp:community_involvement
|
local health initiatives
|
|
gptkbp:conducts_research_on
|
gptkb:Dr._Jane_Smith
|
|
gptkbp:employees
|
gptkb:500
|
|
gptkbp:founded_in
|
gptkb:1990
|
|
gptkbp:founder
|
gptkb:Dr._Max_Mustermann
|
|
gptkbp:headquarters
|
gptkb:Germany
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Biotechnica
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:invention
|
over 50
|
|
gptkbp:investment
|
Venture Capital Firm A
|
|
gptkbp:location
|
gptkb:Berlin
|
|
gptkbp:market
|
global
|
|
gptkbp:mission
|
advancing healthcare through biotechnology
|
|
gptkbp:partnerships
|
various universities
|
|
gptkbp:products
|
biopharmaceuticals
|
|
gptkbp:research_and_development
|
20% of revenue
|
|
gptkbp:research_focus
|
genetic engineering
|
|
gptkbp:revenue
|
100 million USD
15%
|
|
gptkbp:services
|
contract research
|
|
gptkbp:subsidiaries
|
gptkb:Biotechnica_USA
|
|
gptkbp:sustainability_practices
|
eco-friendly processes
|
|
gptkbp:vision
|
leading biotech innovations
|
|
gptkbp:website
|
www.biotechnica.com
|
|
gptkbp:bfsParent
|
gptkb:Arasaka_Corporation
|
|
gptkbp:bfsLayer
|
6
|